Quantitative trait locus on chromosome 20q13 for plasma levels of C-reactive protein in healthy whites: the HERITAGE Family Study.
C-reactive protein (CRP) is a sensitive marker of systemic low-grade inflammation. Increased plasma levels of CRP predict the risk of cardiovascular and metabolic diseases. Although genetic factors account for 30-40% of individual differences in plasma CRP levels, genomic regions contributing to CRP levels remain unknown. We performed a genome-wide linkage scan for plasma CRP levels in healthy whites from the HERITAGE Family Study. CRP was measured with a high-sensitivity assay. Multipoint linkage analyses were performed in 280 sibling pairs with 654 markers using regression and variance components-based methods. Data were adjusted for independent correlates of plasma CRP. We showed the strongest evidence of linkage for plasma CRP levels on chromosome 20q13. Markers which gave suggestive linkages in this region were D20S52 [logarithm of odds (LOD) score 3.18, P = 0.00006], D20S857 (LOD score 2.87, P = 0.00014), D20S869 (LOD score 2.75, P = 0.0002), D20S480 (LOD score 2.59, P = 0.0003), D20S501 (LOD score 2.55, P = 0.0003), D20S840 (LOD score 2.18, P = 0.0008), and D20S876 (LOD score 2.07, P = 0.001). We also detected suggestive linkage on chromosome 5p13 for marker D5S1470 (LOD score 2.23, P = 0.0007). Chromosome 20q13 may contribute to plasma CRP levels in healthy whites. This region contains genes that are important in the inflammatory process and may play a role in the development of chronic inflammatory diseases. The present findings may be useful in the ongoing effort to search for genes contributing to inflammation and to identify individuals at an increased risk of chronic inflammatory diseases.
Lakka
Timo A
TA
Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA. timo.lakka@uku.fi
Rankinen
Tuomo
T
Rice
Treva
T
Leon
Arthur S
AS
Rao
D C
DC
Skinner
James S
JS
Bouchard
Claude
C
D000367:Age Factors; D044383:Black People / Q000235:genetics; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis*; D002170:Canada / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood; D002890:Chromosomes, Human, Pair 20 / Q000235:genetics*; D003276:Contraceptives, Oral; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000517:prevention & control; D015444:Exercise; D005260:Female; D005819:Genetic Markers; D020249:Hormone Replacement Therapy; D006801:Humans; D007249:Inflammation / Q000235:genetics*; D007328:Insulin / Q000097:blood; D008126:Lod Score; D008297:Male; D010101:Oxygen Consumption; D040641:Quantitative Trait Loci; D019655:Quantitative Trait, Heritable; D012494:Sampling Studies; D035781:Siblings; D012907:Smoking; D014280:Triglycerides / Q000097:blood; D014481:United States / Q000453:epidemiology; D044465:White People / Q000235:genetics*; D001741:Black or African American
D008076:Cholesterol, HDL; D003276:Contraceptives, Oral; D005819:Genetic Markers; D007328:Insulin; D014280:Triglycerides; D002097:C-Reactive Protein